Sp703
THE CLINICAL IMPACT OF IBS IN IBD: WHAT WE KNOW AND WHAT WE DON'T
Date
May 20, 2024
Presenter
St James's University Hospital
Tracks
Related Products
COST-EFFECTIVE TESTING AND RATIONAL PHARMACOTHERAPY FOR CONSTIPATIOHN, DIARRHEA, AND PAIN
This session will provide evidence based practical recommendations for managing disorders of gastrointestinal functions…
CLOSTRIDIOIDES DIFFICILE INFECTION INDUCES A PRO-STEATOTIC AND PRO-INFLAMMATORY METABOLIC STATE IN LIVER
BACKGROUND: Recent studies suggest links between _Clostridioides difficile_ infection (CDI) and liver disorders, with non-alcoholic fatty liver disease (NAFLD) increasing CDI risk and CDI exacerbating the progression and prognosis of liver cirrhosis. Moreover, gut dysbiosis, often leading to _C…
Irritable Bowel Syndrome in Inflammatory Bowel Disease: Boundaries Along a Continuum
SOCIETY: AGA IBS-like symptoms in patients with IBD are common, yet presenting a diagnostic and clinical challenge for patients and their providers…
